Skip to content

Clinical trials

Osteosarcoma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteosarcoma Country / region: Australia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20051
20083
20091
20141
20161
20171
20181
20191
20203
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting5
Recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group10
National Cancer Institute (NCI)9
Cellectar Biosciences, Inc.1
Eastern Cooperative Oncology Group1
Eisai Inc.1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteosarcoma23
Sarcoma14
Neuroblastoma11
Medulloblastoma9
Neuroectodermal Tumors, Primitive, Peripheral9
Rhabdomyosarcoma7
Wilms Tumor7
Ependymoma6
Glioma6
Hepatoblastoma6

Trials

Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.